Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)

HIZAL M., ŞENDUR M. A. N., YAŞAR H. A., Bir Yucel K., Arslan C., Ucar G., ...Daha Fazla

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, cilt.26, sa.7, ss.1583-1589, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 7
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1177/1078155219900908
  • Dergi Adı: JOURNAL OF ONCOLOGY PHARMACY PRACTICE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Agricultural & Environmental Science Database, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE
  • Sayfa Sayıları: ss.1583-1589
  • Anahtar Kelimeler: Interferon, neutrophil-lymphocyte ratio, prognosis, renal cell cancer, tyrosine kinase inhibitors, PRETREATMENT NEUTROPHIL, INFLAMMATION, CANCER, IMPACT, PROGRESSION, VALIDATION
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Background